D-Glucose infusion and gestational diabetes induce vasodilatation in humans and increase L-arginine transport and nitric oxide (NO) synthesis in human umbilical vein endothelial cells. High D-glucose (25 mmol/L, 2 minutes) induced membrane hyperpolarization and an increase of L-arginine transport (V max 6.1Ϯ0.7 versus 4.4Ϯ0.1 pmol/g protein per minute) with no change in transport affinity (K m 105Ϯ9 versus 111Ϯ16 mol/L). L-[ 3 H]Citrulline formation and intracellular cGMP, but not intracellular Ca 2ϩ , were increased by high D-glucose. The effects of D-glucose were mimicked by levcromakalim (ATP-sensitive K ϩ channel blocker), paralleled by p42/p44 mapk and Ser 1177 -endothelial NO synthase phosphorylation, inhibited by N G -nitro-L-arginine methyl ester (L-NAME; NO synthesis inhibitor), glibenclamide (ATP-sensitive K ϩ channel blocker), KT-5823 (protein kinase G inhibitor), PD-98059 (mitogen-activated protein kinase kinase 1/2 inhibitor), and wortmannin (phosphatidylinositol 3-kinase inhibitor), but they were unaffected by calphostin C (protein kinase C inhibitor). Elevated D-glucose did not alter superoxide dismutase activity. Our findings demonstrate that the human fetal endothelial L-arginine/NO signaling pathway is rapidly activated by elevated D-glucose via NO and p42/44 mapk . This could be determinant in pathologies in which rapid fluctuations of plasma D-glucose may occur and may underlie the reported vasodilatation in early stages of diabetes mellitus. (Circ Res. 2003;92:64-72.) Human umbilical vein endothelium was isolated (collagenase digestion 0.25 mg/mL) and cultured (37°C, 5% CO 2 , confluent passage 2) in medium 199 containing 5 mmol/L D-glucose, 10% newborn calf serum, 10% fetal calf serum, 3.2 mmol/L L-glutamine, 100 mol/L L-arginine, and 100 U/mL penicillin-streptomycin (primary culture medium). [2] [3] [4] Before an experiment (24 hours), the incubation medium was changed to serum-free medium 199.
T he cationic amino acid L-arginine is the substrate for nitric oxide (NO) synthesis via endothelial NO synthase (eNOS) 1 and is taken up primarily by the Na ϩ -independent high-affinity (K m Ϸ100 to 400 mol/L) systems y ϩ /CAT-1 and y ϩ /CAT-2B (where CAT indicates cationic amino acid transporter) in human umbilical vein endothelial cells (HUVECs). 2,3 L-Arginine transport and NO synthesis (Larginine/NO pathway) are increased in HUVECs from patients with gestational diabetes. 2 Interestingly, long-term incubation (24 hours) of HUVECs from normal pregnancies with elevated D-glucose mimics the effect of gestational diabetes on the L-arginine/NO pathway. 4 In addition, elevated D-glucose for 24 hours 4,5 or 5 days 6 increases eNOS gene expression. A recent report shows that D-glucose infusion induces vasodilatation in humans, 7 and in animal models, an elevation of plasma D-glucose results in rapid (seconds to minutes) vasodilatation. 8 -10 Therefore, rapid fluctuations in the D-glucose level are crucial in maintaining human fetal endothelial function. [2] [3] [4] [5] 11 D-Glucose activates protein kinase C (PKC), an enzyme involved with long-term stimulation of the L-arginine/NO pathway, 5, [12] [13] [14] and (within 1 hour) p42 and p44 mitogen-ac-tivated protein (MAP) kinases (p42/44 mapk ). 5, 14, 15 p42/44 mapk activation may itself be dependent on PKC activation and NO synthesis. 5, 14 However, the effect of short-term incubation with elevated D-glucose on the endothelial L-arginine/NO pathway has not been investigated. 4, 11, 16, 17 The present study shows that a 2-minute incubation with 25 mmol/L D-glucose increases L-arginine transport and NO synthesis in HUVECs. The underlying cellular mechanisms involve phosphorylation of eNOS at Ser 1177 via phosphatidylinositol 3-kinase (PI3-k) and activation of eNOS and p42/ p44 mapk by D-glucose. 18 
L-Arginine Transport
L-Arginine transport (1 Ci/mL, 37°C, 1 minute) was determined in cells preincubated (15 seconds to 5 minutes) with Krebs solution (mmol/L: NaCl 131, KCl 5.6, NaHCO 3 25 , NaH 2 PO 4 1, HEPES 20, CaCl 2 2.5, and MgCl 2 1 [pH 7.4, 37°C]) containing 5 or 25 mmol/L D-glucose, 25 mmol/L L-glucose, or 5 mmol/L D-glucose plus 20 mmol/L D-mannitol (osmotic controls). [2] [3] [4] L-Arginine transport was also determined in Krebs solution in which NaCl was replaced by equimolar concentrations of choline chloride [2] [3] [4] or in cells incubated (30 minutes) with KCl (5.5 to 131 mmol/L), with NaCl decreased equivalently, or with 131 mmol/L KCl for 2, 4, 10, 20, or 30 minutes. In trans-stimulation experiments, cells were preincubated (2 hours) with primary culture medium containing 10 mmol/L L-lysine. Cell-associated radioactivity and data analyses were performed as described. [2] [3] [4] L-Arginine transport was assayed in cells preincubated (30 minutes) with 100 mol/L N G -nitro-L-arginine methyl ester (L-NAME, eNOS inhibitor), 2,3 10 mol/L PD-98059 (MAP kinase kinase 1/2 [MEK1/2] inhibitor), 19 100 mol/L S-nitroso-N-acetyl-L,Dpenicillamine (SNAP, NO donor), 1 mol/L KT-5823 (protein kinase G [PKG] inhibitor), 20 100 nmol/L calphostin C (PKC inhibitor), 21 10 mol/L glibenclamide (ATP-sensitive K ϩ [K ϩ ATP ] channel blocker), 22 1 mol/L levcromakalim (K ϩ ATP activator), 23 or 30 nmol/L wortmannin (PI3-k inhibitor). 24
Membrane Potential
Ci/mL, 15 to 120 seconds), a membrane potential-sensitive probe, 2, 3, 25 was determined in Krebs solution containing 5 or 25 mmol/L D-glucose, 100 mol/L L-arginine, and 5.5 or 131 mmol/L KCl. 2, 3 Resting membrane potential (E m , whole-cell patch clamp) was recorded using an EPC-7 amplifier (List Medical) as described. 2 E m was measured for at least 1 minute in the presence of 5 or 25 mmol/L D-glucose. Only recordings with Ͻ0.1-mV variations were considered. E m was also determined in cells preincubated for 2 hours with 10 mmol/L L-lysine.
PKC Activity
PKC activity ( 32 P incorporation from [␥-32 P]ATP into a synthetic PKC substrate peptide analogue 5 ) was determined in cells exposed to 5 or 25 mmol/L D-glucose (2 minutes) after pretreatment with 100 nmol/L phorbol 12-myristate 13-acetate (5 minutes, PKC activator), 100 nmol/L 4␣-phorbol 12,13-didecanoate (5 minutes, less active phorbol 12-myristate 13-acetate analogue), 100 nmol/L calphostin C (30 minutes), 10 mol/L PD-98059 (30 minutes), 100 mol/L SNAP (5 minutes), 100 mol/L L-NAME (30 minutes), or 30 nmol/L wortmannin (30 minutes).
cGMP Determination
Cells preincubated (30 minutes) in Krebs solution (37°C) containing L-arginine (100 mol/L) and 3-isobutyl-1-methylxanthine (0.5 mmol/L, phosphodiesterase inhibitor), 2,3 in the absence or presence of L-NAME (100 mol/L), were exposed to 5 or 25 mmol/L D-glucose for the last 2 minutes of the 30-minute incubation period with 3-isobutyl-1-methylxanthine. cGMP was determined in HCl-cell extracts by radioimmunoassay. 2, 3 
L-Citrulline Assay
Cells were incubated with L-[ 3 H]arginine (100 mol/L, 4 Ci/mL, 30 minutes, 37°C) in the absence or presence of L-NAME (100 mol/L). Cells were exposed to 5 or 25 mmol/L D-glucose for 30 minutes or for the last 2, 4, 10, or 20 minutes of this incubation period. Some experiments were performed in cells exposed only to L-[ 3 
Intracellular Ca 2؉
Cells on glass coverslips were loaded (30 minutes, 23°C) with the acetoxymethyl derivative of fluo 3 (5 mol/L). Coverslips were transferred to an experimental bath with Krebs solution containing 5 or 25 mmol/L D-glucose, and Ca 2ϩ was imaged using a Zeiss LSM 410 confocal microscope. 4
Western Blots
After pretreatment with 10 mol/L PD-98059 (30 minutes), 100 mol/L SNAP (2 to 5 minutes), or 30 nmol/L wortmannin (30 minutes), the cells were incubated with 5 or 25 mmol/L D-glucose (2 minutes). Cell protein extracts were probed with a primary polyclonal mouse antiphosphorylated (1:1000) or nonphosphorylated (1:1500) p44/p42 mapk , rabbit anti-eNOS (1:2500) or anti-phosphorylated Ser 1177 -eNOS (1:2500) antibodies, and horseradish peroxidaseconjugated goat secondary antibodies as described. 3, 5 Primary polyclonal mouse anti-actin (1:2000) served as the internal control. Proteins were detected by enhanced chemiluminescence and quantified by densitometry (Ultroscan XL enhanced laser densitometer, LKB Instruments). 3, 5 
Semiquantitative PCR
Extracted mRNA (Dynal) was reversed-transcribed into cDNA using oligo(dT 18 ) plus random hexamers (10-mer) and M-MLV reverse transcriptase (Promega) for 1 hour at 37°C. 3 Polymerase chain reactions (PCRs) were performed in 20-L samples (2 L of 10ϫ PCR buffer, 0.8 L of 50 mmol/L Mg 2ϩ , 0.4 L dNTPs, 13.6 L RNase-free H 2 O, 0.2 L Taq DNA polymerase, and 0.5 mol/L sequence-specific oligonucleotide primers for human CAT-1, CAT-2A, or CAT-2B). Samples were incubated (4 minutes, 95°C), followed by 35 cycles of 30 seconds at 95°C, 30 seconds at 57°C, 30 seconds at 72°C, and a final extension for 7 minutes at 72°C. ␤-Actin expression was used as a reference value. Reverse transcription (RT)-PCR products were sequenced in both directions by Taq dideoxy terminator cycle sequencing (automated DNA sequencer 373A, Applied Biosystems). 3 Oligonucleotide primers were as follows: hCAT-1 (sense) 5Ј-CCAGTACTTCCGACGAGTTAGA-3Ј, hCAT-1 (antisense) 5Ј-CATCCACACAGCAAACCGGACC-3Ј, hCAT-2A (sense) 5Ј-TATCCCGATTTTTTTGCTGTGTGC-3Ј, hCAT-2A (antisense) 5Ј-TGCAGTCAACGTGGCAGCAACT-3Ј, hCAT-2B (sense) 5Ј-TCCCAATGCCTCGTGTAATCTA-3Ј, hCAT-2B (antisense) 5Ј-GCATGCTGAAGCCCTGTCTCTGC-3Ј, ␤-actin (sense) 5Ј-AACCGCGAGAAGATGACCCAGATCATCTTT-3Ј, and ␤-actin (antisense) 5Ј-AGCAGCCGTGGCCATCTCTTGCTCGAAGTC-3Ј. Expected size products were as follows: hCAT-1, 450 bp; hCAT-2A, 690 bp; hCAT-2B, 360 bp; and ␤-actin, 350 bp.
SOD Activity and ␣-Tocopherol Experiments
Cells were homogenized in buffer containing 50 mmol/L Tris-(hydroxymethyl)-aminomethane, 100 mmol/L potassium chloride, 0.02% Triton X-100, 100 mmol/L sodium pyrophosphate, and 100 mmol/L sodium fluoride (pH 7.4), which was supplemented with trypsin inhibitors (4 mg/mL aprotinin, 1 mg/mL benzamidine, 5 g/mL leupeptin, and 200 mol/L sodium orthovanadate). Aliquots (1 mg protein/mL) were incubated (25°C, 2 minutes) with potassium phosphate buffer (50 mmol/L, pH 10.2) containing adrenochrome (200 mol/L) and epinephrine (10 mol/L), and absorbance was measured at 480 nm. Superoxide dismutase (SOD) activity was calculated from the inhibition curve for epinephrine auto-oxidation versus protein concentration. Basal absorbance (100% activity) was the reaction in the absence of cell extracts. 26 Cells were also preincubated (30 minutes) with ␣-tocopherol (500 g/mL, 1% ethanol). 27
Materials
Sera, agarose, and buffers were from GIBCO Life Technologies. Collagenase type II (Clostridium histolyticum) was from Boehringer-Mannheim, and Bradford protein reagent was from Bio-Rad Laboratories. L-NAME and SNAP were from Calbiochem. Ethidium 
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Statistical Analysis
Values are meanϮSEM, where n indicates the number of different cell cultures (4 to 8 replicates per experiment). Statistical analyses were carried out on raw data using the Peritz F multiple-means comparison test. 28 A Student t test was applied for unpaired data, and a value of PϽ0.05 was considered statistically significant.
Results
L-Arginine Transport
Elevated D-glucose (2 minutes), but not L-glucose or D-mannitol, stimulated L-arginine transport (half-maximal effect [K 1/2 ] 13Ϯ2 mmol/L D-glucose) ( Figure 1A ). Basal transport rates increased significantly after 30 seconds of exposure to elevated D-glucose (K 1/2 25Ϯ5 seconds), with maximal rates achieved within 1 minute and sustained over 5 minutes ( Figure 1B) . Subsequent experiments were performed using 25 mmol/L D-glucose for 2 minutes. D-Glucose-stimulated L-arginine transport decreased to basal values within 5 minutes after reexposure of cells to 5 mmol/L D-glucose ( Figure 1B ). RT-PCR analysis detected only hCAT-1 and hCAT-2B mRNA in HUVECs ( Figure 1C ). Elevated D-glucose had no effect on the nonsaturable component (K D ) of overall L-arginine transport but increased V max , with no change in apparent K m (Figure 2A , Table 1 ). Cell incubation with L-lysine (10 mmol/L, 2 hours) increased 6.5-fold the L-arginine transport in 5 mmol/L D-glucose ( Figure 2B ). However, L-arginine transport was increased 2.9-fold in cells exposed to 25 mmol/L D-glucose (last 2 minutes of the 2-hour incubation with L-lysine) ( Figure 2B ). D-Glucose stimulation and trans-stimulation by L-lysine of L-arginine transport was unaltered in Na ϩ -free Krebs solution (not shown).
TPP ؉ Influx and Membrane Potential
Elevated D-glucose increased TPP ϩ influx (1.8-fold) and caused membrane hyperpolarization ( Table 2 ). TPP ϩ influx and L-arginine transport were inhibited by KCl-induced membrane depolarization. Glibenclamide (K ϩ ATP channel blocker) blocked D-glucose-increased L-arginine transport and changes in TPP ϩ influx and E m ( Table 2) . Levcromakalim (K ϩ ATP channel activator) hyperpolarized the plasma membrane and increased L-arginine transport and TPP ϩ influx only in 5 mmol/L D-glucose; effects were blocked by glibenclamide ( Table 2 ). The effects of D-glucose were also blocked by wortmannin (not shown). Preloading cells with L-lysine did not alter E m (Ϫ66.1Ϯ0.3 mV, PϾ0.05; nϭ29 cells) compared with control cells (Ϫ67.5Ϯ0.5 mV, PϾ0.05; nϭ45 cells). L-Arginine transport was inhibited by KCl with halfmaximal inhibition at 12Ϯ2 and 17Ϯ4 mmol/L KCl for 5 and 25 mmol/L D-glucose, respectively. The time needed to induce half-maximal inhibition of transport with 131 mmol/L KCl was similar in cells in 5 mmol/L D-glucose (6.5Ϯ0.6 minutes) compared with 25 mmol/L D-glucose (7.2Ϯ0.6 minutes). 
NO Involvement
Elevated D-glucose increased eNOS phosphorylation at Ser 1177 ( Figure 3A ), L-[ 3 H]citrulline ( Figure 3B ), and cGMP accumulation ( Figure 3C ). L-NAME inhibited the effect of D-glucose on cGMP and L-[ 3 H]citrulline formation but did not alter eNOS-Ser 1177 phosphorylation (not shown). However, wortmannin inhibited D-glucose-induced eNOS phosphory-lation at Ser 1177 , cGMP, and L-[ 3 H]citrulline formation. Similar results were found in cells exposed to 25 mmol/L D-glucose for the last 4, 10, or 20 minutes of the 30-minute incubation period with L-[ 3 H]arginine (not shown). Intracellular Ca 2ϩ in cells incubated with 25 mmol/L D-glucose for 2 minutes (42Ϯ7 nmol/L) was not statistically different (PϾ0.05, nϭ125 cells) from values in cells incubated with 5 mmol/L D-glucose (35Ϯ5 nmol/L).
L-NAME also inhibited the effect of D-glucose on L-arginine transport V max (Table 1) , TPP ϩ influx, and E m ( Table 2) ; however, L-NAME did not alter TPP ϩ influx or E m in 5 mmol/L D-glucose. Other experiments show that SNAP (NO donor) induces TPP ϩ influx, L-arginine transport, and membrane hyperpolarization only in 5 mmol/L D-glucose ( Table 2 ) and that dibutyryl cGMP (dbcGMP) increased L-arginine transport ( Figure 4A ) and TPP ϩ influx ( Figure 4B ). The effects of D-glucose and dbcGMP were blocked by KT-5823, a PKG inhibitor ( Table 2 ).
PKC and MAP Kinase Involvement
PKC activity was unaltered at up to 5 minutes of incubation with high D-glucose ( Figure 5A ) or after the addition of SNAP (not shown). Furthermore, calphostin C (PKC inhibitor) had no effect on D-glucose-increased L-arginine transport ( Figure 5B ), TPP ϩ influx, or NO synthesis (not shown). However, longer incubation with elevated D-glucose (Ͼ10 minutes) increased membrane PKC activity (not shown), confirming our previous observations in HUVECs. 5 In contrast, high D-glucose induced p42/p44 mapk phosphorylation ( Figure 6A) , an effect blocked by PD-98059 and mimicked by brief exposure (2 minutes) to SNAP ( Figure 6B ). Interestingly, the effect of D-glucose on p42/44 mapk phosphorylation was blocked by wortmannin ( Figure 6C ). PD-98059 also blocked the stimulatory effects of elevated D-glucose and SNAP on TPP ϩ influx, L-arginine transport, and E m ( Table 2) . L-NAME 125Ϯ22 3.6Ϯ0.5 † 0.029Ϯ0.007 † 0.003Ϯ0.0008 L-Arginine transport (100 mol/L, 37°C) in cells preincubated (30 minutes) with 5 mmol/L D-glucose, in absence or presence of 100 mol/L PD-98059 or 100 mol/L L-NAME, and exposed (2 minutes 
SOD Activity and ␣-Tocopherol Effect
Discussion
The present study establishes that D-glucose induces a rapid concentration-dependent stimulation of L-arginine transport in HUVECs. This effect requires NO synthesis associated with increased phosphorylation of eNOS at Ser 1177 and activation of p42/p44 mapk and PI3-k, and it is independent of PKC and intracellular Ca 2ϩ changes. These findings provide the first evidence that short-term hyperglycemia activates the L-arginine/NO signaling pathway in human fetal endothelium. L-Arginine transport is mediated by systems y ϩ /CATs, 2,3,12 y ϩ L, 29, 30 and b 0,ϩ 12 in HUVECs, with the first likely predominating at the physiological concentration of extracellular L-arginine. The cDNAs for four potential human y ϩ transporters (hCAT-1, hCAT-2B, hCAT-2A, and hCAT-4) have been sequenced. 31 L-Arginine transport in HUVECs occurs with relatively high affinity (K m Ϸ80 to 100 mol/L) and, as confirmed here, is Na ϩ independent and inhibited by membrane depolarization. 2, 3, 32 Because of their similar kinetic properties, CAT-1 and CAT-2B are hard to distinguish at the functional level. 31 Our results show that both high-affinity hCAT-1 (K m Ϸ100 to 200 mol/L) and hCAT-2B (K m Ϸ200 to 400 mol/L), but not the low-affinity hCAT-2A transporter (K m Ϸ2 to 5 mmol/L), are present in HUVECs, confirming previous reports. 3, 33 CAT-1 is more sensitive than CAT-2B to trans-stimulation by cationic amino acids. 3, 31, 34 When we preloaded HUVECs with L-lysine, L-arginine transport was increased by Ϸ7-fold in 5 mmol/L D-glucose. However, the L-lysine trans-stimulatory effect was less effective (Ϸ3-fold) in cells exposed for 2 minutes to 25 mmol/L D-glucose. Because L-arginine transport is trans-stimulated by 9.8-fold or 1.8-fold in Xenopus oocytes injected with hCAT-1 or hCAT-2B mRNA, respectively, 34 transstimulation in HUVECs in 5 mmol/L D-glucose may be preferentially mediated by hCAT-1. The reduced transstimulation of transport in high D-glucose may result from a state of maximal activity of L-arginine transporters already induced by L-lysine; therefore, high D-glucose could not further increase L-arginine transport. In addition, the possi- bility that L-lysine-stimulated L-arginine transport was due to membrane hyperpolarization is unlikely because E m was unaltered in L-lysine-preloaded cells.
Long-term incubation (24 hours) of HUVECs with high D-glucose increases V max for L-arginine transport. 4 The present study shows that acute (2-minute) D-glucose increases V max for L-arginine transport without altering the apparent K m . As noted above, L-arginine transport is sensitive to changes in extracellular K ϩ and E m . Because high D-glucose induced membrane hyperpolarization, stimulation of L-arginine transport could result from changes in E m . The stimulatory effect of D-glucose on TPP ϩ influx and L-arginine transport was blocked by glibenclamide, a K ϩ ATP channel blocker. In addition, levcromakalim (K ϩ ATP activator) 23 mimics D-glucoseinduced changes in E m , L-arginine transport, and TPP ϩ influx. K ϩ ATP channels are expressed in the endothelium 35 and are activated by D-glucose 36 ; thus, the effects of D-glucose may involve changes in the activity of glibenclamide-sensitive K ϩ ATP channels. D-Glucose (24 hours) also increases eNOS expression 4 and activity 2 in HUVECs. In the present study, eNOS activity was increased in HUVECs exposed for 1 to 5 minutes to high D-glucose, an effect associated with increased phosphorylation of eNOS at Ser 1177 , a residue known to be associated with eNOS activation. 37 The rapid eNOS stimulatory effect of D-glucose was not further increased by longer incubations periods with D-glucose, which could be due to a maximal and sustained activation of eNOS acutely induced by elevated D-glucose. Because D-glucose did not alter basal intracellular 
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Ca 2ϩ , it is likely that rapid eNOS activation by D-glucose is Ca 2ϩ independent, supporting recent observations of Ca 2ϩindependent eNOS activation in HUVECs. 37, 38 D-Glucoseinduced phosphorylation of eNOS at Ser 1177 , L-arginine transport, and TPP ϩ influx were blocked by wortmannin, suggesting that the PI3-k pathway could be involved in the effects of D-glucose. L-Arginine transport could be determinant for eNOS activity 11 ; however, the possibility that the D-glucose-induced increase of L-citrulline production was due to elevated L-arginine transport seems unlikely, inasmuch as D-glucose-induced NO synthesis was unaltered in the absence of extracellular L-arginine. L-NAME blocked D-glucose-increased L-arginine transport and NO synthesis in HUVECs. This inhibitor does not alter basal L-arginine transport in the endothelium [2] [3] [4] 39 ; thus, NO most likely mediates changes in L-arginine transport, as suggested in bovine aortic endothelium. 40 This result is similar to that found in HUVECs from patients with gestational diabetes; L-arginine transport in these cells is increased concomitantly with membrane hyperpolarization and NO synthesis, and this increase is inhibited by blocking NO synthase. 2 NO causes membrane hyperpolarization in the endothelium, 3, 36 and NO (from SNAP) has been shown to cause comparable increases in TPP ϩ influx and L-arginine transport and to cause membrane hyperpolarization to those caused by D-glucose, although SNAP treatment did not further enhance the effects of high D-glucose, in HUVECs. These findings support the hypothesis that NO acutely modulates L-arginine transport by a mechanism that involves membrane hyperpolarization.
NO-altered K ϩ channel activity may occur by both indirect mechanisms via cGMP and direct NO action on channels. 36 Our results show that the D-glucose increases in L-arginine transport and TPP ϩ influx were mimicked by dbcGMP and blocked by the PKG inhibitor KT-5823. In addition, Dglucose-induced membrane hyperpolarization was also blocked by KT-5823. Thus, modulation of ion channel activity (and hence, L-arginine transport) could be due to the activation of PKG downstream from NO synthesis.
PKC activity is increased in subjects with diabetes mellitus or in endothelium chronically exposed to high D-glucose. 12, 16, 17 Activation of diacylglycerol/phorbol estersensitive PKC isozymes activates eNOS and the NOdependent increased p42/p44 mapk phosphorylation in HUVECs exposed for 24 hours to high D-glucose. 5 However, 25 mmol/L D-glucose for 1 to 5 minutes did not alter PKC activity in this cell type, suggesting that the rapid D-glucose effect on L-arginine transport was PKC independent. Because D-glucose induces a rapid (2-minute) p42/p44 mapk phosphorylation and because inhibition of the p42/p44 mapk phosphorylation by PD-98059 also inhibits the D-glucose increase in TPP ϩ influx and L-arginine transport, it is likely that p42/ p44 mapk activation is involved in this pathway. Activation of p42/44 mapk requires PI3-k activity in HUVECs. 41 Our results show that D-glucose-induced p42/44 mapk phosphorylation is blocked by wortmannin, suggesting that the D-glucose effect requires PI3-k activity in HUVECs. SNAP-increased p42/ p44 mapk phosphorylation and L-arginine transport were blocked by PD-98059, complementing results showing that NO, via cGMP, causes rapid p42/p44 mapk phosphorylation in the endothelium. 4, 42 Because D-glucose-induced and NOinduced membrane hyperpolarization are blocked by PD-98059, p42/p44 mapk activation could modulate ion channel activity and L-arginine transport in HUVECs.
Elevated D-glucose leads to overproduction of oxygenderived free radicals in several cell types. 11, 16, 17 We found that SOD activity in HUVECs was unaltered by 25 mmol/L D-glucose and that SOD or ␣-tocopherol did not block the effects of D-glucose, suggesting that short-term incubation with elevated D-glucose would not generate enough oxygenderived free radicals to induce changes in the L-arginine/NO pathway in HUVECs.
The present study has established that high D-glucose rapidly activates the L-arginine/NO pathway in HUVECs. The effect of D-glucose involves PI3-k-dependent, but PKCindependent and intracellular Ca 2ϩ -independent, eNOS and p42/44 mapk activation. These results complement previous observations in animal models in which elevated plasma D-glucose results in a rapid (seconds to minutes) vasodilatation 8 -10 and observations of D-glucose-induced vasodilatation in humans. 7 Local NO synthesis could be one mechanism by which rapid alterations in plasma D-glucose result in vasodilatation and may have important implications in diabetic patients, in whom plasma D-glucose concentrations may change rapidly. 11, 12, 16, 17 
